Health Affairs

Health Affairs, 25, no. 6 (2006): 1637-1647 doi: 10.1377/hlthaff.25.6.1637 © 2006 by Project HOPE	New Online   CBO Scoring Reform   Rising Insurance Rates   Health Care Investment   Consumers on Reform   Sen. Harkin on Child Obesity   Sen. Enzi: Fighting Obesity

This Article Abstract Full Text (HTML) Reprint (PDF) Online Appendices Erratum Submit a response to this article Comments: View responses Alert me when this article is cited Alert me when Comments are posted Alert me if a correction is posted Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My Personal Archive Download to Citation Manager Reprints & Permissions Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (8) Citing Articles via Google Scholar Google Scholar Articles by Kesselheim, A. S. Articles by Avorn, J. Search for Related Content PubMed PubMed Citation Articles by Kesselheim, A. S. Articles by Avorn, J. Related Collections Legal/Regulatory Issues Medicaid Business Of Health Pharmaceuticals Research And Technology Health Spending

Extensions Of Intellectual Property Rights And Delayed Adoption Of Generic Drugs: Effects On Medicaid Spending

Aaron S. Kesselheim, Michael A. Fischer and Jerry Avorn

View larger version (14K): [in a new window]   EXHIBIT 2 Generic Market Share Of Metformin, Amoxicillin/Clavulanate, And Omeprazole In Medicaid, By Quarter, 2001–2004

View larger version (18K): [in a new window]   EXHIBIT 6 Total Calculated And Projected Medicaid Spending For Generic Amoxicillin/Clavulanate, Metformin, And Omeprazole During The Full Study Period

                      What's this?